Nrx Pharmaceuticals Inc (NRXP)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Nrx Pharmaceuticals Inc Azioni (NRXP) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-03-31	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Income/Loss From Continuing Operations Before Tax	30.20% -5.512	-7.897	-6.528	-4.332	-6.062
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	30.20% -5.512	-7.897	-6.528	-4.332	-6.062
Net Income/Loss	30.20% -5.512	-7.897	-6.528	-4.332	-6.062
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INCY

$86.64

1.40%

GMAB

$27.54

0.58%

SMMT

$25.98

9.16%

BNTX

$112.46

8.66%

INSM

$145.10

1.80%

ONC

$341.80

7.24%